Tracheostomy in ICU With a Double Lumen Endotracheal Tube
- Conditions
- Neurological DiseaseAcute Respiratory FailureHeart Failure
- Interventions
- Device: Double lumen endotracheal tube tracheostomy
- Registration Number
- NCT01691222
- Lead Sponsor
- University of Genova
- Brief Summary
Percutaneous tracheostomy in Intensive care unit (ICU) is performed with the use of flexible fiberoptic bronchoscope inside the conventional single lumen endotracheal tube owned by the patients. This situation may lead to many disadvantages for ventilation and airway protection of critically ill patients during the procedures. The use of double lumen endotracheal tube dedicated to the percutaneous tracheostomies may:
1. improve the ventilation of patients during the procedure,
2. protect the posterior tracheal wall from damage related to the different step of tracheostomies,
3. protect the lungs from blood and secretions coming down from the chosen site of tracheostomy.
So the aim of this study is to evaluate the oxygenation, gas exchange, ventilation and complications of percutaneous tracheostomies performed in ICU with a dedicated double lumen endotracheal tube.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- age ≥ 18 years and at least one of following criteria:
- prolonged endotracheal intubation
- prolonged mechanical ventilation
- difficult/prolonged weaning
- inability to protect the airway
- infection of neck tissues
- previous surgical neck interventions
- recent surgical interventions or fracture of the cervical spine
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Double lumen endotracheal tube tracheostomy Double lumen endotracheal tube tracheostomy Tracheostomy with a dedicated double lumen endotracheal tube
- Primary Outcome Measures
Name Time Method change in gas-exchange at the baseline and the end of the procedure (average time expected for the procedure is 30 minutes) The investigator will perform an arterial blood gas to evaluate PaO2/FiO2 ratio
- Secondary Outcome Measures
Name Time Method early complications in the first 24 hours from the end of the procedure early complications are:multiple intubation attempts (more than 1), accidental extubation, paratracheal insertion, injuries to blood vessels in the neck, oesophageal injury, accidental decannulation, malposition of the tracheostomy tube, tracheal cuff puncture, multiple punctures (more than 1), surgical conversion and percutaneous tracheostomy failure, minor bleeding (compressible), major bleeding (incompressible), pneumothorax,
change in air-trapping at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes) the investigator will record auto-PEEP at the of expiration as a measure of air-trapping
change in peak airway pressure at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes) the investigator will record peak airway pressure
change in plateau airway pressure at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes) the investigator will record plateau airway pressure
change in arterial carbon dioxide at the baseline and at the end of the procedure (average time expected for the procedure is 30 minutes) the investigator will perform an arterial blood gas to evaluate PaCO2
late complications from the 2nd day ofter the procedure until the ICU discharge (expected average of 2 weeks) late complications are: minor bleeding (compressible), major bleeding (incompressible) tracheostomy puncture site infection, subglottic stenosis, fracture of a tracheal cartilage, granuloma.
Trial Locations
- Locations (2)
University of Genoa
🇮🇹Genoa, Italy
University of Naples "Federico II"
🇮🇹Naples, Italy